Christine Stuhlmiller

VP, Program Management at Proteovant Therapeutics

Christine has 17+ years of experience in healthcare, most recently as Executive Director, Global Product Development and Supply Program Management BMS/Celgene.

Location

New York, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Proteovant Therapeutics

Proteovant Therapeutics is a biotechnology company that utilizes protein degradation research in the development of medicines for diseases.


Employees

11-50

Links